Hormone replacement therapy and arterial blood pressure in postmenopausal women with hypertension

Blood Pressure

Volumn 14, Issue 1, 2005, Pages 38-44

  Karalis, Ioannis ^a   Beevers, D Gareth ^a   Beevers, Michele ^a   Lip, Gregory Y H ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

Hormone replacement therapy; Hypertension; Menopause

Indexed keywords

ANTIHYPERTENSIVE AGENT; CHOLESTEROL; CONJUGATED ESTROGEN; ESTROGEN; GESTAGEN; TIBOLONE;

ADULT; ARTERIAL PRESSURE; ARTICLE; ATTENUATION; BLOOD PRESSURE MEASUREMENT; BLOOD PRESSURE REGULATION; BODY WEIGHT; BODY WEIGHT DISORDER; CHOLESTEROL BLOOD LEVEL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ETHNOLOGY; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MENOPAUSAL SYNDROME; MENOPAUSE; OUTPATIENT DEPARTMENT; PREECLAMPSIA; PRIORITY JOURNAL; SYSTOLIC BLOOD PRESSURE; WEIGHT GAIN;

ANTIHYPERTENSIVE AGENTS; ARTERIES; BLOOD PRESSURE; BODY WEIGHT; CHOLESTEROL; CONTINENTAL POPULATION GROUPS; DRUG EVALUATION; FEMALE; HORMONE REPLACEMENT THERAPY; HUMANS; HYPERTENSION; LONGITUDINAL STUDIES; MIDDLE AGED; POSTMENOPAUSE;

EID: 15944417536     PISSN: 08037051     EISSN: 16511999     Source Type: Journal    
DOI: 10.1080/08037050510008788     Document Type: Article

References (30)

1. Belchetz PE. Hormonal treatment of postmenopausal women. N Engl J Med. 1994;330:1062.
2. The Writing Group for the PEPI Trial. Effects of hormone therapy on bone mineral density: results from the postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA. 1996;276:1389-96.
3. Grodstein F, Stampfer MJ, Colditz GA, et al. Postmenopausal hormone therapy and mortality. N Engl J Med. 1997;336: 1769-75.
4. The Writing Group for the PEPI Trial. Effects of estrogen or estrogen/progestin regimens on heart disease risk factors in postmenopausal women. The postmenopausal estrogen/progestin interventions (PEPI) trial. JAMA. 1995;273: 199-208.
5. Butkevich A, Abraham C, Phillips RA. Hormone replacement therapy and 24-hour blood pressure profile of postmenopausal women. Am J Hypertens. 2000;13:1039-41.
6. Cacciatore B, Paakkari I, Hasselblatt R, et al. Randomized comparison between orally and transdermally administered hormone replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women. Am J Obstet Gynecol. 2001;184:904-9.
7. Posthuma WF, Westendorp RG, Vandenbroucke JP. Cardioprotective effect of hormone replacement therapy in postmenopausal women: is the evidence biased? BMJ. 1994;308:1268-9.
8. Hulley S, Grady D, Bush T, et al. The Heart and Estrogen/progestin Replacement Study (HERS) Research Group. Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. JAMA. 1998;280:605-13.
9. Grady D, Herrington D, Bittner V, et al. Cardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/Progestin Replacement Study follow up (HERS II). JAMA. 2002;288:49-57.
10. Hulley S, Furberg C, Barrett-Connor E, et al. Noncardiovascular disease outcomes during 6.8 years of hormone therapy. Heart and Estrogen/Progestin Replacement Study follow up (HERS II). JAMA. 2002;288:58-66.
11. Viscoli CM, Brass LM, Kernan WN, et al. A clinical trial of Estrogen-Replacement therapy after ischemic stroke. N Engl J Med. 2001;345:1243-9.
12. Cherry N, Gilmour K, Hanaford P, et al., (the ESPRIT team), Oestrogen therapy for prevention of reinfarction in postmenopausal women: a randomised placebo controlled trial. Lancet. 2002;360:2001-8.
13. Wassertheil-Smoller S, Hendrix SL, Limacher M, et al. Effect of Estrogen plus Progestin on stroke in postmenopausal women. The Women's Health Initiative: a randomized trial. JAMA. 2003;289:2673-84.
14. The Million Women Study Collaborators, Breast cancer and hormone-replacement therapy in Million Women Study. Lancet. 2003;362:419-27.
15. Chasan-Taber L, Wilett WC, Manson JE, et al. Prospective study of oral contraceptives and hypertension among women in the United States. Circulation. 1996;94: 483-9.
16. Lip GYH, Beevers M, Churchill D, Beevers DG. Hormone replacement therapy and blood pressure in hypertensive women. J Hum Hypertens. 1994;8:491-4.
17. Kawecka-Jaszcz K, Czarnecka D, Olszanecka A, et al. The effect of hormone replacement therapy on arterial blood pressure and vascular compliance in postmenopausal women with arterial hypertension. J Hum Hypertens. 2002;16:509-16.
18. Umeda M, Ichikawa S, Kanda T, et al. Hormone replacement therapy increases plasma level of angiotensin II in postmenopausal hypertensive women. Am J Hypertens. 2001;14:206-11.
19. Butkevich A, Abraham C, Phillips RA. Hormone replacement therapy and 24-hour blood pressure profile of postmenopausal women. Am J Hypertens. 2000;13:1039-41.
20. Cacciatore B, Paakkari I, Hasselblatt R, et al. Randomized comparison between orally and transdermally administered replacement therapy regimens of long-term effects on 24-hour ambulatory blood pressure in postmenopausal women. Am J Obstet Gynecol. 2001;184:904-9.
21. Utian WH. Effect of postmenopausal estrogen therapy on diastolic blood pressure and body weight. Maturitas. 1978;1:3.
22. Wren BG, Routledge DA. Blood pressure changes. Oestrogens in climacteric women. Med J Aust. 1981;2: 528-31.
23. Pripp U, Hall G, Csemiczky G, et al. A randomized trial on effects of hormone replacement therapy on ambulatory blood pressure and lipoprotein levels in women with coronary artery disease. J Hypertens. 1999;17:1379-86.
24. Schunkert H, Danser AHJ, Hense HW, et al. Effects of estrogen replacement therapy on the rennin-angiotensin system in postmenopausal women. Circulation. 1997;95: 39-45.
25. Mercuro G, Zoncu S, Piano D, et al. Estradiol-17beta reduces blood pressure and restores the normal amplitude of the circadian blood pressure rhythm in postmenopausal hypertension. Am J Hypertens. 1998;11:909-13.
26. Mercuro G, Zoncu S, Pilia I, et al. Effects of acute administration of transdermal estrogen on postmenopausal women with systemic hypertension. Am J Cardiol. 1997;80: 652-5.
27. Miya Y, Sumino H, Ichikawa S, et al. Effects of hormone replacement therapy on left ventricular hypertrophy and growth-promoting factors in hypertensive postmenopausal women. Hypertens Res. 2002;25:153-9.
28. Hayward CS, Samaras K, Campbell L, Kelly RP. Effect of combination hormone replacement therapy on ambulatory blood pressure and arterial stiffness in diabetic postmenopausal women. Am J Hypertens. 2001;14:699-703.
29. Kornhauser C, Malacara JM, Garay ME, Perez-Luque EL. The effect of hormone replacement therapy on blood pressure and cardiovascular risk factors in menopausal women with moderate hypertension. J Hum Hypertens. 1997;11:405-11.
30. Affinito P, Palomba S, Bonifacio M, et al. effects of hormonal replacement therapy in postmenopausal hypertensive patients. Maturitas. 2001;40:75-83.